Prediction: Lilly Will Trade at Record High in 12 Months
Eli Lilly stock is surging on fresh obesity-drug data, fueling bets that the name could push toward a record high wit...
We evaluate which retirement option—index fund or target date fund—fits your timeline, risk profile, and tax strategy for a smoother retirement.
26,044 articlesEli Lilly stock is surging on fresh obesity-drug data, fueling bets that the name could push toward a record high wit...
On a June trading day, Payoneer Global surged on takeover chatter, highlighting how M&A rumors can move fintech names...
AI memory demand is reshaping a sleepy sector. Learn how to gain exposure to Samsung, Hynix, and Micron with a smart,...
As Kevin Warsh takes the helm, investors await his first Fed rate decision amid sticky inflation and a shifting economy.
With the Fed set to speak in the next hours, investors sift through recent data as inflation cools but remains above ...
ServiceNow stock sits in the mid-$90s as AI disruption reshapes enterprise software. This article lays out a fresh 20...
A high-yield AI-focused ETF sounds tempting, but a big payout can hide risks. This article breaks down how the divide...
BP weighs UK North Sea exits as part of a sweeping divestment plan, prompting debate over whether the group will stay...
SpaceX has entered another slide in its public debut era. This article breaks down what a second day of losses could ...
Bitcoin just dropped below 60K, prompting a careful look at what happens next. This guide uses historical patterns to...
Single residents aim to live in Manhattan without roommates, but success hinges on an investment plan that covers hig...
Dividend investors face a crowded field. This article compares Pfizer and Verizon Communications to answer pfizer ver...